Format

Send to

Choose Destination

See 1 citation found using an alternative search:

See comment in PubMed Commons below
J Crohns Colitis. 2013 Aug;7(7):e263-70. doi: 10.1016/j.crohns.2012.10.012. Epub 2012 Nov 20.

Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis.

Author information

  • 1Evangelisches Krankenhaus Kalk, Innere Medizin, Köln, Germany. kruis@evkk.de

Abstract

BACKGROUND:

Predictive factors for a mild course of Crohn's disease (CD) may have therapeutic consequences, but as yet have not been identified.

AIMS:

To identify baseline factors that predict mild CD and design a predictive scoring system.

METHODS:

A retrospective, multicenter study of newly diagnosed CD patients allocated to mild CD (no therapy, mesalazine only, or mesalazine with a single initial short course of low-dose prednisone) or moderate CD (all other patients including resected patients).

RESULTS:

162 patients (median follow-up 43 months) were analyzed: 47 mild CD and 115 moderate CD. For mild CD versus moderate CD, mean age at first diagnosis was higher (41.1 versus 33.9 years, p=0.02), mean C-reactive protein (CRP) concentration was lower (1.6 versus 3.6 mg/L, p<0.01), and perianal lesions were less frequent (0% versus 10.4%, p=0.02). The combined incidence of complications (stenosis, any type of fistula, extraintestinal complications or fever) was 21.3% in mild CD versus 35.7% in moderate CD (p=0.07). A scoring system based on age, CRP, endoscopic severity (adapted Rutgeert's score), perianal lesions and combined incidence of complications was developed which can predict a mild prognosis at the initial diagnosis, giving patients the chance of simplified therapy and accelerated step-up in the event of treatment failure.

CONCLUSIONS:

Approximately a third of CD patients experience a mild disease course and require only basic therapy. A possible scoring system to predict mild CD which may avoid overtreatment and unnecessary risks for the patient and costs is suggested.

Copyright © 2012. Published by Elsevier B.V.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk